Wednesday, November 21, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $META.V, TSXV: $N.V, CSE: $CURA.C

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $META.V, TSXV: $N.V, CSE: $CURA.C



Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $META.V, TSXV: $N.V, CSE: $CURA.C

This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa


Delta, Kelowna, BC - November 21, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences  an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: TSX: $META.V, TSXV: $N.V, CSE: $CURA.C

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
Today we will be looking at announcements from National Access Cannabis Corp. (TSXV: META), Namaste Technologies Inc. (TSXV: N) and Curaleaf, Inc. (CSE: CURA).
National Access Cannabis Corp., a best-practices leader in delivering secure, safe, and responsible access to legal cannabis in Canada, today announced that another eight NewLeaf Cannabis™ retail locations have received cannabis retail licenses and are expected to open this week in Alberta and one new Meta Cannabis Supply Co™ ("META") store has received a cannabis retail license and is expected to open this week in Manitoba. The addition of nine new stores more than doubles the national number of NAC-owned and licensed cannabis retail stores to 17 - the most of any cannabis retailer in the country, excluding the Government of New Brunswick.
NAC is looking to open a total of 50 locations between META and NewLeaf across Canada by the end of the year and plans to have a total of 150 retail locations operational during 2019, subject to regulatory approvals. With the aligned brand values of META and NewLeaf, NAC is well-positioned to support Canadian consumers and usher in a new era of responsible cannabis consumption.
"NAC, META and NewLeaf have quickly become established and effective leaders in Canada's cannabis retail market," said Mark Goliger, CEO of NAC. "We have a bold vision to lead recreational cannabis retail in this country and to date we have backed that up in a big way."
Namaste Technologies Inc. announced that the Company's wholly-owned subsidiary, Cannmart Inc. has signed an Asset Purchase Agreement with 1181530 BC Ltd. to acquire the domain Buds2go.ca. Subject to the terms of the Agreement, Cannmart purchased the Buds2go.ca domain along with social media accounts and all intellectual property in connection therewith including trademark applications in exchange for a cash payment of $300,000. The 1181530 BC Ltd. management team signed a 6-month consulting agreement to assist with integration and operations.
The acquisition of Buds2go.ca is strategic in nature as the domain has established high-ranking organic search results for many targeted and valuable keywords, and supports the Company's vision to become a global leader in cannabis e-commerce and technology. The Buds2go.ca domain receives approximately 400,000 site visits per month, with an average visit duration of 6 minutes and a bounce-rate of roughly 31%. The site visits, search traffic and SEO rankings of Buds2go.ca would be difficult to replicate and provide strong long-term value for the company.
The Company reported that it has also concurrently completed an integration with the Buds2go.ca domain and has launched a new website which is powered by Cannmart. This will allow patients to order products from Buds2go.ca through a regulated channel and have access to inventory fed directly through Cannmart. Further to the Company's October 29th, 2018 news release, Cannmart signed a Patient Services Agreement with 1181530 BC Ltd. to offer users access to the Company's online telemedicine platform, NamasteMD Inc.
Curaleaf, Inc., one of the largest and fastest growing vertically integrated cannabis operators in the United States, today announced the launch of Curaleaf Hemp, a line of premium hemp-based CBD products.
Curaleaf Hemp was developed by an experienced team of scientists and product experts. The natural, non-intoxicating products meet the strictest quality standards and are derived from hemp farmed in the United States. Curaleaf Hemp's products are made with simple, natural ingredients and are infused with essential oils such as lavender, lemon, jasmine, ginger and vanilla to add an additional layer of benefits for overall wellness.
The range of products are available for purchase online at www.curaleafhemp.com and at select retailers nationwide.
The company also announced today that the Company has continued its expansion in Arizona by acquiring dispensary operator Midtown Roots. Midtown Roots is the only dispensary located in the heart of downtown Phoenix, and is easily accessible across the street from the Thomas/Central Ave light rail public transit stop. It will be Curaleaf's 5th dispensary in the Phoenix metro area and the 33rd Curaleaf dispensary nationwide.
With the acquisition of dispensary operator Midtown Roots, Curaleaf has now served over 70,000 patients in Arizona between its 5 locations.
"Curaleaf is a leading medical cannabis brand that is recognized across the country for its quality and expertise," said Steve Cottrell, president of Curaleaf Arizona. "With this rebrand, we will bring additional resources to Midtown Roots to support upgrades that will enhance the patient experience as well as the continued education of our staff."
Current Midtown Roots patients can anticipate the same experience they've come to know and love; friendly budtenders, great products and community events, such as regular meditation classes and bingo, will all continue under the new name. To celebrate, Curaleaf Midtown will host a Grand Opening Party on Friday, November 30
This podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB:CLSH) - more info and details can be found at our disclaimer and disclosure page at Investorideas.com
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit: http://www.clsholdingsinc.com
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411

Investorideas.com - #CBD Stocks to Watch - Pain Treatment and Sports Medicine: Orion Nutraceuticals (CSE: $ORI.C), Aurora (TSX: $ACB.TO), CannTrust (TSX: $TRST.TO), Kalytera (TSXV: $KALY.V)

Investorideas.com - #CBD Stocks to Watch - Pain Treatment and Sports Medicine: Orion Nutraceuticals (CSE: $ORI.C), Aurora (TSX: $ACB.TO), CannTrust (TSX: $TRST.TO), Kalytera (TSXV: $KALY.V)



#CBD Stocks to Watch - Pain Treatment and Sports Medicine: Orion Nutraceuticals (CSE: $ORI.C), Aurora (TSX: $ACB.TO), CannTrust (TSX: $TRST.TO), Kalytera (TSXV: $KALY.V)


Point Roberts, WA and Kelowna, BC - November 21, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource for cannabis stocks releases a snapshot looking at CBD and its future role as a pain treatment in healthcare, and how it is being advocated and embraced by professional athletes.
The World Anti-Doping Agency (WADA) officially removed cannabidiol (CBD) from its Prohibited Substances List effective January 1, 2018 and that has opened up a lot of opportunity for athletes looking for more natural pain treatment solutions and companies in the space.
In June of this year, The BIG3 basketball league announced they will allow players to use cannabidiol (CBD) as a pain treatment and for recovery. "The BIG3 is uniquely positioned in professional sports as a player-powered league that looks at our players as partners not property," BIG3 co-founder and co-CEO Jeff Kwatinetz said in a statement. "As a testament to our relationship with our players, we listened to their feedback on CBD, as well as feedback from professionals in the regulatory and CBD industry, and decided to take this major step to support their health."
NFL Players are some of the biggest advocates of the use of CBD for pain and sports injuries and as a Washington Post article explains, "No professional sport has so many outspoken proponents of marijuana's medicinal qualities, but then again, no sport is as closely associated with pain and injury."
Looking at capitalizing on the CBD market opportunity, cannabis life science company Orion Nutraceuticals Inc. (CSE: ORI), just announce today it is entering the sports medicine CBD market with the addition of Shannon Ford-Smith, sports healthcare and CBD product expert to its advisory board.
From the news: Shannon Ford-Smith has a uniquely diverse background that includes education, construction, consumer goods as well as experience building and leading companies in the sports healthcare sector. She has over a decade of experience building, leading and establishing business direction.
Continued: Throughout her career she has developed deep market insight into the healthcare field. Her recent executive role at Floydʼs of Leadville as Director of Business Development includes the development of Aeliza (a medical grade CBD product line) and oversight of the Companyʼs expansion and growth into the Canadian market, hiring and leading the execution of a common vision of success while mitigating risk. She spearheaded development of the Aeliza line and personally oversaw every detail, from product development and formulation, manufacturing, business development, marketing, strategy, as well as bridging the gap between the medical world and cannabis.
Continued: "We are extremely pleased to add Shannon Ford-Smith to Orion Nutraceutical's advisory board", said Jonathan Fiteni, CEO of Orion. "Her impressive resume includes a strong background in both healthcare and business development. Shannon's experience in creating the CBD product line Aeliza will prove instrumental in the creation of Orion's own sports medicine CBD product lines."
Also looking at CBD for pain treatment, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) and McGill University announced in August, the launch of an international collaborative medical research project that will comprehensively examine the therapeutic impact and human health outcomes of cannabidiol (CBD) oil as a therapy for chronic pain and related anxiety and depression.
From the news: "Based on our extensive experience with more than 60,000 registered Canadian patients, we believe CBD to be one of the most impactful medical compounds to become legally available to people in need of non-addictive therapies to treat pain," stated Terry Booth, CEO. "Our support for and involvement with this project underlines Aurora's leadership in the medical cannabis space, as well as our long-term commitment to a science-based approach to deepen understanding of this amazing substance."
Taking a similar path and partnering with a major University, CannTrust Holdings Inc. (TSX: TRST), partnered with McMaster University on medicinal cannabis research for chronic pain and for designing more effective, safer treatment protocols in public health policies.
The race is on for companies in the sector and new advancements are being made. In late September, Kalytera Therapeutics, Inc. (TSX V: KALY ) (OTCQB: KALTFannounced a major step forward in its program to develop the first cannabinoid-derived pain treatment targeting activation of alpha3 glycine receptors.
"When activated, the alpha3 glycine receptor strongly blocks pain signals from being sent to the brain. Kalytera, and its research partner, Beetlebung Pharma Ltd. ("BPL"), have carried out a medicinal chemistry program to identify a novel analogue of cannabidiol ("CBD") that will block such pain signals via the activation of the alpha3 glycine receptor channel in the spinal cord. To date, no company has introduced into the market an agent specifically targeting this receptor."
As far as CBD's role in sports, it is really just the beginning. According to an article in SportsNet ,   "Former star NFL running back Ricky Williams thinks cannabis legalization in Canada is "a huge step forward" towards professional sports leagues like the NFL softening their stances on athletes using marijuana therapeutically."
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
Follow us on our Cannabis Social Media
This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.aspDisclosure: this news article featuring ORI.C is a paid for news release on Investorideas.com – third party, Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800-665-0411

Tuesday, November 20, 2018

Investorideas.com - #Cannabisstocks: Orion Nutraceuticals (CSE: $ORI.C) Adds Shannon Ford-Smith, #Sports Healthcare and #CBD Product Expert, to Advisory Board

Investorideas.com - #Cannabisstocks: Orion Nutraceuticals (CSE: $ORI.C) Adds Shannon Ford-Smith, #Sports Healthcare and #CBD Product Expert, to Advisory Board

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabis Stocks - Weekend Unlimited (CSE: YOLO - FSE: 0OS1) Enters Retail Cannabis Space In Alberta

Investorideas.com - #Cannabis Stocks - Weekend Unlimited (CSE: YOLO - FSE: 0OS1) Enters Retail Cannabis Space In Alberta

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - CSE New #Cannabis Listing - CannaOne Technologies Inc. (CNNA)

Investorideas.com - CSE New #Cannabis Listing - CannaOne Technologies Inc. (CNNA)




Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.C) (CSE: $CHOO.C)

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.C) (CSE: $CHOO.C)



Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.V) (CSE: $CHOO.C)

This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa


Delta, Kelowna, BC - November 20, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences  an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (OTCQB: $GBLX) (CSE: $GABY.C) (TSXV: $HVT.V) (CSE: $CHOO.C)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
This month's podcast is brought to you by our exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Today we will be looking at announcements from GB Sciences, Inc. (OTCQB: GBLX), Gabriella's Kitchen Inc. (CSE: GABY), Harvest One Cannabis Inc. (TSXV:HVT) and Choom™ (CSE: CHOO) (OTCQB: CHOOF).
GB Sciences, Inc. and the Universidad de Sevilla (USE) announced the filing of a provisional patent application on the creation of myrcene-containing nanoparticles for use in the treatment of neuropathic pain.
"We have achieved a significant research milestone in the creation of the myrcene-containing nanoparticles that are at the core of our patent-pending, myrcene-based complex mixtures for the treatment of neuropathic pain," said Dr. Andrea Small-Howard. "Our colleagues at the Universidad de Sevilla had to overcome serious physical and chemical challenges to stabilize the very small myrcene molecules that are prone to evaporating. USE is also creating nanoparticle versions of the other compounds in our myrcene-containing complex mixtures; however, these other terpenoids and cannabinoids should not be as challenging because they are bigger, and USE has discovered ways to stabilize small molecules, like myrcene."
Back in October of 2017, GB Sciences, Inc. entered into a Contract Research Agreement with the Universidad de Sevilla to develop a time-released version of GB Sciences' proprietary, THC-free, myrcene-based chronic pain formulations, which contain a mixture of terpenoids and cannabinoids. USE researchers have created a prototype of the myrcene-containing nanoparticles, and GB and USE will begin functional testing of these formulations.
Gabriella's Kitchen Inc., an innovative and leading-edge cannabis wellness company, announced that it has submitted an application to have its common shares quoted on the OTCQB Venture Market (the "OTCQB") and its intention to seek The Depositary Trust Company ("DTC") eligibility. The listing of the Company's common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements.
The Company believes that being listed on the OTCB will expand the Company's presence in the U.S. and provide current and future U.S.-based shareholders with greater access to, and ease of trading in, GABY's shares. The Company will continue to trade on the Canadian Securities Exchange under its existing symbol "GABY".
"Admission to the OTCQB is part of our long-term strategy to introduce the Company to a broader range of institutional and retail investors in the U.S.," stated Margot Micallef, GABY's Founder and CEO. "We have established a strong operating base in the U.S. which includes products available in over 3,400 major retail locations, our cannabis manufacturing facility, and our cannabis and mainstream distribution networks. By providing U.S. investors with the opportunity to easily invest in GABY through our OTCQB listing, we fulfill yet another step in executing our strategy of becoming the category leader in the global cannabis edibles and wellness space."
Harvest One Cannabis Inc. announced that it has completed its previously announced acquisition of 100% of Israeli-based Phytotech Therapeutics Ltd. from Australian-based MMJ Group Holdings Ltd.
In consideration for the acquisition of PTL, Harvest One paid C$1,000,000 in cash and 8,326,694 Harvest One common shares.
Founded in 2014, Phytotech has developed advanced oral delivery formulations for cannabinoid-based prescription drugs and holds an exclusive worldwide licensing agreement with Yissum Research Development Company, the commercial arm of the University of Jerusalem, for a proprietary lipid nanotechnology.
With the acquisition, Harvest One's wholly-owned subsidiary Satipharm will gain access to advanced patents in favourable jurisdictions that can be used for further R&D and product development to aggressively pursue the rapidly evolving cannabis oils market.
PTL was also responsible for administrating the successful clinical trials using Satipharm's proprietary capsules. The Phase 1 clinical trials demonstrated the safety and high performance of the oral capsule technology, including the effective delivery profile of cannabidiol ("CBD"), while Phase 2 clinical trials were completed in 2017, returning favourable results in the treatment of pediatric epilepsy.
Choom™, an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, announced it has acquired Clarity Cannabis Medical Centre Inc. and affiliates doing business as Clarity Medical Centres.
Chris Bogart, President & CEO states, "Our goal is to build a dominant national cannabis retail brand. The acquisition of Clarity Medical Centres allows Choom to service the entire Canadian cannabis market, beyond just the adult use channel. As cannabis becomes more widely accepted as an alternative to pharmaceuticals, increasingly, patients with medical conditions will require professional medical advice on the benefits and best use of cannabis as a treatment."
The acquisition includes five new medical centres along with a proprietary telemedicine platform that provides important education, access and expertise for referring patients in the use of cannabis for medical purposes. The Clarity Medical Centres approach makes it simple for new patients to access legal medical cannabis products in Canada and streamlines the process of registering with a licensed producer.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit: http://www.clsholdingsinc.com
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411

Investorideas.com - The Future of #CBD for Pain Treatment and Sports Medicine: Orion Nutraceuticals (CSE: $ORI.C), Aurora Cannabis (TSX: $ACB.TO), CannTrust Holdings (TSX: $TRST.TO), Kalytera Therapeutics (TSXV: $KALY.V)

Investorideas.com - The Future of #CBD for Pain Treatment and Sports Medicine: Orion Nutraceuticals (CSE: $ORI.C), Aurora Cannabis (TSX: $ACB.TO), CannTrust Holdings (TSX: $TRST.TO), Kalytera Therapeutics (TSXV: $KALY.V)



The Future of #CBD for Pain Treatment and Sports Medicine: Orion Nutraceuticals (CSE: $ORI.C), Aurora Cannabis (TSX: $ACB.TO), CannTrust Holdings (TSX: $TRST.TO), Kalytera Therapeutics (TSXV: $KALY.V)


Point Roberts, WA and Kelowna, BC - November 20, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource for cannabis stocks releases a snapshot looking at CBD and its future role as a pain treatment in healthcare, and how it is being advocated and embraced by professional athletes.
The World Anti-Doping Agency (WADA) officially removed cannabidiol (CBD) from its Prohibited Substances List effective January 1, 2018 and that has opened up a lot of opportunity for athletes looking for more natural pain treatment solutions and companies in the space.
In June of this year, The BIG3 basketball league announced they will allow players to use cannabidiol (CBD) as a pain treatment and for recovery. "The BIG3 is uniquely positioned in professional sports as a player-powered league that looks at our players as partners not property," BIG3 co-founder and co-CEO Jeff Kwatinetz said in a statement. "As a testament to our relationship with our players, we listened to their feedback on CBD, as well as feedback from professionals in the regulatory and CBD industry, and decided to take this major step to support their health."
NFL Players are some of the biggest advocates of the use of CBD for pain and sports injuries and as a Washington Post article explains, "No professional sport has so many outspoken proponents of marijuana's medicinal qualities, but then again, no sport is as closely associated with pain and injury."
Looking at capitalizing on the CBD market opportunity, cannabis life science company Orion Nutraceuticals Inc. (CSE: ORI), just announce today it is entering the sports medicine CBD market with the addition of Shannon Ford-Smith, sports healthcare and CBD product expert to its advisory board.
From the news: Shannon Ford-Smith has a uniquely diverse background that includes education, construction, consumer goods as well as experience building and leading companies in the sports healthcare sector. She has over a decade of experience building, leading and establishing business direction.
Continued: Throughout her career she has developed deep market insight into the healthcare field. Her recent executive role at Floydʼs of Leadville as Director of Business Development includes the development of Aeliza (a medical grade CBD product line) and oversight of the Companyʼs expansion and growth into the Canadian market, hiring and leading the execution of a common vision of success while mitigating risk. She spearheaded development of the Aeliza line and personally oversaw every detail, from product development and formulation, manufacturing, business development, marketing, strategy, as well as bridging the gap between the medical world and cannabis.
Continued: "We are extremely pleased to add Shannon Ford-Smith to Orion Nutraceutical's advisory board", said Jonathan Fiteni, CEO of Orion. "Her impressive resume includes a strong background in both healthcare and business development. Shannon's experience in creating the CBD product line Aeliza will prove instrumental in the creation of Orion's own sports medicine CBD product lines."
Also looking at CBD for pain treatment, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) and McGill University announced in August, the launch of an international collaborative medical research project that will comprehensively examine the therapeutic impact and human health outcomes of cannabidiol (CBD) oil as a therapy for chronic pain and related anxiety and depression.
From the news: "Based on our extensive experience with more than 60,000 registered Canadian patients, we believe CBD to be one of the most impactful medical compounds to become legally available to people in need of non-addictive therapies to treat pain," stated Terry Booth, CEO. "Our support for and involvement with this project underlines Aurora's leadership in the medical cannabis space, as well as our long-term commitment to a science-based approach to deepen understanding of this amazing substance."
Taking a similar path and partnering with a major University, CannTrust Holdings Inc. (TSX: TRST), partnered with McMaster University on medicinal cannabis research for chronic pain and for designing more effective, safer treatment protocols in public health policies.
The race is on for companies in the sector and new advancements are being made. In late September, Kalytera Therapeutics, Inc. (TSX V: KALY ) (OTCQB: KALTFannounced a major step forward in its program to develop the first cannabinoid-derived pain treatment targeting activation of alpha3 glycine receptors.
"When activated, the alpha3 glycine receptor strongly blocks pain signals from being sent to the brain. Kalytera, and its research partner, Beetlebung Pharma Ltd. ("BPL"), have carried out a medicinal chemistry program to identify a novel analogue of cannabidiol ("CBD") that will block such pain signals via the activation of the alpha3 glycine receptor channel in the spinal cord. To date, no company has introduced into the market an agent specifically targeting this receptor."
As far as CBD's role in sports, it is really just the beginning. According to an article in SportsNet ,   "Former star NFL running back Ricky Williams thinks cannabis legalization in Canada is "a huge step forward" towards professional sports leagues like the NFL softening their stances on athletes using marijuana therapeutically."
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
Follow us on our Cannabis Social Media
This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.aspDisclosure: this news article featuring ORI.C is a paid for news release on Investorideas.com – third party, Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news